Cook´s Balloon Versus Dinoprostone for Labor Induction of Term Pregnancies With Fetal Growth Restriction

Fetal Growth Retardation Clinical Trial

— COLIGROW  

Official title:

Cook´s Balloon Versus Dinoprostone for Labor Induction of Term Pregnancies With Fetal Growth Restriction (COLIGROW)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05774236
• Other study ID #: COLIGROW
• Secondary ID: 2021-001726-22PI
• Status: Recruiting
• Phase: Phase 3
• Start date: March 27, 2023
• Est. completion date: September 27, 2025

Study information

• Verified date: April 2023
• Source: Hospital Universitario 12 de Octubre
• Contact: Ignacio Herraiz, MD, PhD
• Phone: +34913908310
• Email: ignacio.herraiz[@]salud.madrid.org
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this clinical trial is to compare how two methods for cervical ripening work in a population of singleton pregnancies with late-onset fetal growth restriction (FGR) at term.

The main question it aims to answer is whether Cook´s balloon (a mechanical method) is superior to vaginal dinoprostone (a pharmacological method) in achieving a vaginal delivery, without increasing neonatal morbidity.

Participants will be randomized to receive Cook´s balloon (experimental group) or vaginal dinoprostone (control group) for cervical ripening.

Researchers will compare both groups to see if Cook´s balloon is associated with a higher rate of vaginal delivery than vaginal dinoprostone and is not related to increased neonatal morbidity.

Description:

Late-onset fetal growth restriction (FGR) represents the most common subtype of FGR (70-80%). The greatest risk for these fetuses appears once term pregnancy is reached, when stressful situations are added to their status of relative hypoxia, such as the appearance of contractions and funicular compression. Thus, it has been shown that from week 37-38 the risk of intrauterine mortality increases and there is a general consensus not to prolong these pregnancies beyond this period. In this situation, induction of labor is usually preferred over elective caesarean delivery. However, these fetuses have an increased risk of cesarean section for suspected fetal distress.

Mechanical methods for cervical ripening are associated with less uterine stimulation with a lower rate of tachysystole than prostaglandins. Therefore, these methods have been proposed as the optimal approach for late-onset FGR, since they could reduce the rate of cesarean sections for suspected fetal distress. However, there is no published randomized controlled trials on the use of different methods of cervical ripening for labor induction in late-onset FGR.

Thus, the investigators postulate that, in late-onset FGR, cervical ripening with a mechanical method (Cook´s balloon) achieves a higher percentage of vaginal deliveries than a pharmacological method (vaginal dinoprostone), being safe for both the mother and the newborn.

The main aim of this study is to evaluate whether cervical ripening with Cook balloon for labor induction at term gestation of singleton pregnancies with late-onset FGR achieves a higher rate of vaginal delivery compared to the use of vaginal dinoprostone, without increasing neonatal morbidity.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 172
• Est. completion date: September 27, 2025
• Est. primary completion date: May 27, 2025
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Singleton pregnancy

• Age = 18 years

• Gestational age (GA) dated by first trimester ultrasound = 37+0 weeks

• Cephalic presentation

• Stage I fetal growth restriction, defined as the presence of at least one of these two criteria:

1. Estimated fetal weight (EFW) < 3rd percentile

2. EFW < 10th percentile and at least one of the following: 2.1) Umbilical artery pulsatility index > 95th percentile or 2.2) Cerebral-placental index < 5th percentile

• Bishop score < 7

• Intact fetal membranes

• No previous caesarean section

• No contraindications for vaginal delivery or labor induction.

Exclusion Criteria:

• Major fetal malformation

• Fetal genetic abnormality

• Fetal congenital infection

Related Conditions & MeSH terms

• Fetal Growth Retardation

Intervention

Device:
• Cook´s balloon
Cervical ripening for induction of labor with a mechanical method (Cook´s balloon)

Drug:
• Vaginal dinoprostone
Cervical ripening for induction of labor with a pharmacological method (vaginal dinoprostone)

Locations

Country	Name	City	State
Spain	Hospital Clinic i Provincial	Barcelona
Spain	Hospital Sant Joan de Déu	Esplugues de Llobregat	Barcelona
Spain	Hospital Universitario 12 de Octubre	Madrid

Sponsors (3)

Lead Sponsor	Collaborator
Hospital Universitario 12 de Octubre	Instituto de Salud Carlos III, Spanish Clinical Research Network - SCReN

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of vaginal delivery	To assess whether cervical ripening with a Cook balloon for induction of labor of term pregnancies with FGR increases the rates of vaginal delivery with respect to the use of vaginal dinoprostone, without increasing neonatal morbidity.	2 days (from admission to delivery)
Secondary	Rate of cesarean sections due to suspected fetal distress	To assess whether cervical ripening with a Cook balloon for induction of labor of term pregnancies with FGR decreases the rates of cesarean sections due to suspected fetal distress with respect to the use of vaginal dinoprostone	2 days (from admission to delivery)
Secondary	Induction-to-delivery interval	Comparison of the time interval between the onset of cervical ripening and delivery between the two arms	2 days (from admission to delivery)
Secondary	Neonatal morbidity	To analyze the neonatal morbidity through the MAIN score (Morbidity assessment index for newborns) of neonatal morbidity and the duration of admissions to the Neonatal Intensive Care Unit (NICU).	From delivery to discharge of the newborn (up to 1 month)